MIRA INFORM REPORT

 

 

Report No. :

302625

Report Date :

12.01.2015 

 

IDENTIFICATION DETAILS

 

Name :

CLARIS INJECTABLES LIMITED (w.e.f. 03.09.2014)

 

 

Formerly Known As :

CLARIS LIFESCIENCES INTERNATIONAL LIMITED (w.e.f. 30.04.2010)

CLARIS INTERNATIONAL LIMITED

 

 

Registered Office :

Claris Corporate Headquarters, Near Parimal Crossing, Ellisbridge, Ahmedabad – 380 006, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

08.06.2005

 

 

Com. Reg. No.:

04-046211

 

 

Capital Investment / Paid-up Capital :

Rs.0.501 million

 

 

CIN No.:

[Company Identification No.]

U24230GJ2005PLC046211

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AACCC6252B

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Injectables, Healthcare Products, Drugs, Medicines, Medical Preparations and Hospital Products.

 

 

No. of Employees :

1500 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown 

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in 2005, whereas has not performed any commercial operations since its inception.

 

Moreover, the parent company has transferred its specialty injectable business for India by way of slump sale (as a going concern) into the subject as on November 02, 2014.

 

However, trade relations are improving. Business is active. Payments are unknown.

 

In view of potential financial effects which will be adjusted into upcoming financials for FYE 14, the company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION DECLINED BY

 

Name :

Mr. Ankit Modi

Designation :

Finance Head

Contact No.:

91-79-26563331

Date :

09.01.2015 

 

 

LOCATIONS

 

Registered Office :

Claris Corporate Headquarters, Near Parimal Crossing, Ellisbridge, Ahmedabad – 380 006, Gujarat

Tel. No. :

91-79-26563331/ 66309339

Fax No. :

91-79-26308053

E-Mail :

secretarial.corp@clarislifesciences.com

secretarial.corp@clarisinj.com

Website :

www.clarisinj.com

 

 

DIRECTORS

 

AS ON 17.06.2014

 

Name :

Mr. Amish Pravinchandra Vyas

Designation :

Director

Address :

89/400, Saraswati Nagar, Near Azad Society, Ambawadi, Ahmedabad – 380 015, Gujarat, India

Date of Birth/Age :

17.09.1970

Date of Appointment :

10.12.2014

DIN No. :

00168292

PAN No.:

AAKPV3987B

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85110GJ2001PLC039161

HEALTHNEXT LIMITED

Director

15-01-2003

15-01-2003

05-10-2009

Active

NO

2

U24230GJ2005PLC046211

CLARIS INJECTABLES LIMITED

Director

10-12-2014

08-06-2005

-

Active

NO

3

U73100GJ2005PLC047024

XCELRIS LABS LIMITED

Director

07-11-2005

07-11-2005

30-12-2009

Active

NO

4

U66910GJ1995PTC028208

DIALYS HEALTHCARE PRIVATE LIMITED

Director

12-11-2005

12-11-2005

05-10-2009

Strike off

NO

5

U85110GJ1993PLC019685

MEDICAL TECHNOLOGIES LIMITED

Director

12-11-2005

12-11-2005

12-11-2005

Amalgamated

NO

6

L85110GJ1994PLC022543

CLARIS LIFESCIENCES LIMITED

Whole-time director

03-07-2012

10-11-2006

04-12-2012

Active

NO

7

U45202GJ2007PLC050061

CLARIS INFRASTRUCTURE LIMITED

Director

21-02-2007

21-02-2007

-

Active

NO

8

U63020GJ2008PLC053516

ZED SUPPLYCHAIN LIMITED

Director

07-04-2008

07-04-2008

20-09-2008

Active

NO

9

U24230GJ2012PTC072692

CLARIS OTSUKA PRIVATE LIMITED

Director

12-11-2012

12-11-2012

31-07-2013

Active

NO

 

 

Name :

Mr. Chandrasingh Shivrambhai Purohit

Designation :

Director

Address :

17, Rajvi Emeralds, Near Gala Gymkhana, Bopal, Ahmedabad – 380 054, Gujarat, India

Date of Birth/Age :

15.09.1973

Date of Appointment :

08.06.2005

DIN No. :

00199651

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230GJ2005PLC046211

CLARIS INJECTABLES LIMITED

Director

08-06-2005

08-06-2005

-

Active

NO

2

L85110GJ1994PLC022543

CLARIS LIFESCIENCES LIMITED

Whole-time director

03-07-2012

03-07-2009

-

Active

NO

3

U24230GJ2012PTC072692

CLARIS OTSUKA PRIVATE LIMITED

Director

12-11-2012

12-11-2012

31-07-2013

Active

NO

 

 

Name :

Mr. Arjun Sushilkumar Handa

Designation :

Director

Address :

Sharanya, Judges Bunglows Road, Vastrapur, Bodakdev, Ahmedabad – 380 054, Gujarat, India

Date of Appointment :

10.12.2014

DIN No. :

00159413

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

L85110GJ1994PLC022543

CLARIS LIFESCIENCES LIMITED

Managing director

26-09-2011

19-02-2001

-

Active

NO

2

U65910GJ1996PTC030641

SARJAN FINANCIAL PRIVATE LIMITED

Director

30-09-2005

26-03-2005

-

Amalgamated

NO

3

U65923GJ1994PTC021125

DARSHNIL FINANCIAL PRIVATE LIMITED

Director

30-09-2006

12-11-2005

13-08-2014

Active

NO

4

U65993GJ2006PLC048993

PI. CAPITAL LIMITED

Director

02-09-2006

02-09-2006

28-02-2008

Strike off

NO

5

U72900GJ2000PLC038445

ACCELARIS TECHNOLOGIES LIMITED

Director

29-09-2012

04-11-2006

-

Active

NO

6

U45201GJ2007PLC050984

ATARAXIA ESTATES LIMITED

Director

29-05-2007

29-05-2007

28-02-2008

Active

NO

7

U72200GJ1995PLC026341

ENTHRILLS INFOTECH LIMITED

Director

07-07-2007

07-07-2007

28-02-2008

Active

NO

8

U24239GJ2008PLC052927

CYGNUS LABORATORIES LIMITED

Director

14-02-2008

14-02-2008

15-04-2009

Active

NO

9

U45201GJ2008PLC054381

AVENTURE INFRASTRUCTURE LIMITED

Director

03-07-2008

03-07-2008

27-05-2009

Active

NO

10

U40100GJ2008PLC054493

ABELLON ENERGY LIMITED

Director

16-07-2008

16-07-2008

01-12-2008

Active

NO

11

U67100GJ1996PTC030640

PRARABDH FINANCIAL PRIVATE LIMITED

Additional director

21-05-2009

21-05-2009

05-01-2010

Active

NO

12

U73100MH1996NPL100174

THE PHARMACEUTICAL FORM-FILL-SEAL ASSOCIATION OF INDIA

Director

29-09-2011

29-09-2011

-

Active

NO

13

U70102GJ2012PTC069220

CLARIS HOLDINGS PRIVATE LIMITED

Director

28-02-2012

28-02-2012

-

Active

NO

14

U24230GJ2012PTC072692

CLARIS OTSUKA PRIVATE LIMITED

Director

12-11-2012

12-11-2012

-

Active

NO

15

U51909GJ2013PTC075961

ATHANAS ENTERPRISE PRIVATE LIMITED

Director

09-07-2013

09-07-2013

-

Active

NO

16

U51397GJ2013PTC076030

BELLISSIMO ENTERPRISE PRIVATE LIMITED

Director

15-07-2013

15-07-2013

-

Active

NO

17

U24230GJ2005PLC046211

CLARIS INJECTABLES LIMITED

Director

10-12-2014

01-08-2014

-

Active

NO

18

AAA-2000

PRARISHODHANA CONSULTANCY LLP

Designated Partner

10-08-2010

10-08-2010

-

Active

NO

19

AAB-0436

AKHILESH VENTURE HOLDINGS LLP

Designated Partner

31-07-2012

31-07-2012

-

Active

NO

20

AAB-1418

ELDORO INFRA-TECH LLP

Designated Partner

28-09-2012

28-09-2012

-

Active

NO

21

AAB-1459

ZENA INFRABUILD AND MANAGEMENT LLP

Designated Partner

03-10-2012

03-10-2012

-

Active

NO

22

AAC-0285

VITALIS INFRATECH LLP

Designated Partner

24-01-2014

24-01-2014

-

Active

NO

 

 

Name :

Mr. Chetankumar Satyendra Majmudar

Designation :

Director

Address :

B-201, Suryaketu Tower, Near Sambhav Press, Bodakdev, Vastrapur, Ahmedabad – 380 015, Gujarat, India

Date of Appointment :

10.12.2014

 

DIN No. :

00166936

PAN No. :

ACVPM0491L

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

L85110GJ1994PLC022543

CLARIS LIFESCIENCES LIMITED

Whole-time director

01-07-2014

02-10-2003

-

Active

NO

2

U85110GJ1993PLC019685

MEDICAL TECHNOLOGIES LIMITED

Director

19-03-2004

19-03-2004

05-01-2010

Amalgamated

NO

3

U24230GJ2004PLC045046

OGEN NUTRITION LIMITED

Director

23-11-2004

23-11-2004

-

Active

NO

4

U24230GJ2004PLC045045

AVER LABORATORIES LIMITED

Director

23-11-2004

23-11-2004

05-10-2009

Strike off

NO

5

U73100GJ2005PLC047024

XCELRIS LABS LIMITED

Director

07-11-2005

07-11-2005

30-12-2009

Active

NO

6

U72900GJ2000PLC038445

ACCELARIS TECHNOLOGIES LIMITED

Director

26-11-2005

26-11-2005

28-02-2008

Active

NO

7

U72200GJ1995PLC026341

ENTHRILLS INFOTECH LIMITED

Additional director

07-07-2007

07-07-2007

28-02-2008

Active

NO

8

U63020GJ2008PLC053516

ZED SUPPLYCHAIN LIMITED

Director

07-04-2008

07-04-2008

20-09-2008

Active

NO

9

U45202GJ2007PLC050061

CLARIS INFRASTRUCTURE LIMITED

Director

05-06-2010

27-03-2010

-

Active

NO

10

U24230GJ2005PLC046211

CLARIS INJECTABLES LIMITED

Director

10-12-2014

01-08-2014

-

Active

NO

 


 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 17.06.2014

 

Names of Shareholders

 

 

No. of Shares

Claris Lifesciences Limited, India

 

50000

Chandrasingh Shivrambhai Purohit

 

10

Amish Pravinchandra Vyas

 

10

Nirav Mehta

 

10

Chetankumar Satyendra Majmudar

 

10

Kirit Shah

 

10

Roopesh Madan

 

10

Total

 

50060

 

AS ON 17.06.2014

 

Equity Share Break up (Percentage of Total Equity)

Category

Percentage of Holding

Bodies corporate

99.88

Directors or relatives of Directors

0.06

Other top fifty shareholders

0.06

Total

100.00

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Injectables, Healthcare Products, Drugs, Medicines, Medical Preparations and Hospital Products.

 

 

Products :

  • Injectables
  • Healthcare Products
  • Drugs
  • Medicines
  • Medical Preparations
  • Hospital Products

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

1500 (Approximately)

 

 

Bankers :

Banker Name

Canara Bank

Branch Address

Prime Corporate Branch, 104, Jyoti Commercial Comp, Near Shyamal Cross Road, Satellite, Vejalpur, Ahmedabad – 380 015, Gujarat, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Deloitte Haskins and Sells

Chartered Accountants

Address :

'Heritage', 3rd Floor, Gujarat Vidyapith, Off Ashram Road, Ahmedabad – 380 014, Gujarat, India

PAN No.:

AABFD7919A

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Holding Company :

Claris Lifesciences Limited

 

 

Fellow Subsidiaries :

  • Claris Lifesciences Venezuela C. A.
  • Claris Produtos Farmaceuticos Do Brasil Ltda.
  • Pt. Claris Lifesciences Indonesia
  • Claris Lifesciences Colombia Ltda
  • Catalys Venture Cap Limited
  • Icubix Infotech Limited
  • Claris Lifesciences Philippines Inc.
  • Claris Lifesciences De Mexico SA de CV
  • Claris Lifesciences (UK) Limited
  • Claris Lifesciences Inc.
  • Claris Lifesciences and CIA Chile Limitada
  • Claris Lifesciences (Aust) Pty Limited
  • OGEN Nutrition Limited
  • Claris SteriOne
  • Claris Pharmaservices
  • Claris Infrastructure Limited
  • Claris Otsuka Limited (Associate Company 20% holding of Claris Lifesciences Limited (upto 31.07.2013 it was wholly owned subsidiary)

 

 

Enterprise over which KMP are able to exercise Significant :

  • Accelaris Technologies Limited

 

 

CAPITAL STRUCTURE

 

AS ON 17.06.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

500000

Equity Shares

Rs.10/- each

Rs.5.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

50060

Equity Shares

Rs.10/- each

Rs.0.501 million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.12.2013

31.12.2012

31.12.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

0.501

0.501

0.501

(b) Reserves & Surplus

(0.854)

(0.808)

(0.749)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

(0.353)

(0.307)

(0.248)

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.719

0.657

0.604

(d) Long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.719

0.657

0.604

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

0.056

0.010

0.010

(c) Other current liabilities

0.006

0.068

0.062

(d) Short-term provisions

0.000

0.000

0.000

Total Current Liabilities (4)

0.062

0.078

0.072

 

 

 

 

TOTAL

0.428

0.428

0.428

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

0.000

0.000

0.000

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.427

0.427

0.427

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

0.427

0.427

0.427

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

0.000

0.000

0.000

(c) Trade receivables

0.000

0.000

0.000

(d) Cash and cash equivalents

0.001

0.001

0.001

(e) Short-term loans and advances

0.000

0.000

0.000

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

0.001

0.001

0.001

 

 

 

 

TOTAL

0.428

0.428

0.428

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.12.2013

31.12.2012

31.12.2011

 

SALES

 

 

 

 

 

Revenue from Operations

0.000

0.000

0.000

 

 

Other Income

0.017

0.000

0.000

 

 

TOTAL                                    

0.017

0.000

0.000

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Other Expenses

0.063

0.059

0.063

 

 

TOTAL                                    

0.063

0.059

0.063

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

(0.046)

(0.059)

(0.063)

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

(0.046)

(0.059)

(0.063)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION        

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

(0.046)

(0.059)

(0.063)

 

 

 

 

 

Less

TAX                                                                 

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

(0.046)

(0.059)

(0.063)

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

(0.93)

(1.17)

(1.27)

 

 


KEY RATIOS

 

PARTICULARS

 

 

31.12.2013

31.12.2012

31.12.2011

Net Profit Margin

(PAT/Sales)

(%)

0.00

0.00

0.00

 

 

 

 

 

Operating Profit Margin

(PBDIT/ Sales)

(%)

0.00

0.00

0.00

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(4600.00)

(5900.00)

(6300.00)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.13

0.19

0.25

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.02

0.01

0.01

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.12.2011

31.12.2012

31.12.2013

 

(INR in Mlns.)

(INR in Mlns.)

(INR in Mlns.)

Share Capital

0.501

0.501

0.501

Reserves & Surplus

(0.749)

(0.808)

(0.854)

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

(0.248)

(0.307)

(0.353)

 

 

 

 

Long Term borrowings

0.000

0.000

0.000

Short Term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.12.2011

31.12.2012

31.12.2013

 

(INR in Mlns)

(INR in Mlns)

(INR in Mlns)

Sales

0.000

0.000

0.000

 

 

 

 

 

 

 


NET PROFIT MARGIN

 

Net Profit Margin

31.12.2011

31.12.2012

31.12.2013

 

(INR in Mlns)

(INR in Mlns)

(INR in Mlns)

Sales

0.000

0.000

0.000

Profit

(0.063)

(0.059)

(0.046)

 

 

 

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

OPERATIONS:

 

During the year Company has made a loss of Rs.0.046 million due to non full fledge operation of Company. The Directors hope for better performance and for better progress of company in coming years.

 

 

INDEX OF CHARGES

 

S. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10528638

31/10/2014

5,394,400,000.00

CANARA BANK

PRIME CORPORATE BRANCH, 104, JYOTI COMMERCIAL COMP, NEAR SHYAMAL CROSS ROAD, SATELLITE, VEJALPUR, AHMEDABAD, GUJARAT - 380015, INDIA

C31958564

2

10528664

31/10/2014

5,394,400,000.00

CANARA BANK

PRIME CORPORATE BRANCH, 104, JYOTI COMMERCIAL COMP, NEAR SHYAMAL CROSS ROAD, SATELLITE, VEJALPUR, AHMEDABAD, GUJARAT - 380015, INDIA

C31971633

 

 

WEBSITE DETAILS:

 

PRESS RELEASES/ ARTICLES:

 

CLARIS LIFESCIENCES COMPLETES TRANSFER OF SPECIALITY INJECTABLE BUSINESS

 

November 2, 2014

 

NEW DELHI: Sterile injectable manufacturer Claris Lifesciences today said it has completed transfer of itsSpeciality Injectable Business by way of slump sale to its wholly-owned subsidiary Claris Injectables Limited.

 

In a BSE filing, Claris Lifesciences said: "It has completed transfer of its Speciality Injectable Business by way of slump sale (as a going concern) to its wholly-owned subsidiary Claris Injectables Limited."

 

The company said its Board of Directors on July 4, 2014 had approved the transfer of its Speciality Injectable Business subject to approval of shareholders.

 

On September 3, shareholders of the company approved the transfer along with all employees, assets and liabilities at a consideration not less than its book value.

 

"The management team being retained in the company will concentrate on the strategic - business and financial growth and development of all the businesses in the group," the company said.

 

Claris Lifesciences added that it "will continue to handhold and support the Joint Venture with Otsuka Pharmaceutical Factory and Mitsui and Co Limited."

 

In 2012, the Ahmedabad-based drugmaker entered into a JV agreement with two Japanese firms -- Otsuka Pharmaceutical and Mitsui and Co Limited - for its injectable business in India and Emerging Markets.

 

As per the deal, the company transferred common solutions, anti-infective, plasma volume expanders and parenteral nutrition therapies business for India and Emerging Markets to the new JV- Claris-Otsuka.

The Indian company received Rs.10500.000 millions as a part of the transaction from Claris-Otsuka. The joint venture is valued at Rs.13130.000 millions.

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :  No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.39

UK Pound

1

Rs.94.17

Euro

1

Rs.73.61            

 

 

INFORMATION DETAILS

 

Information Gathered by :

PRT

 

 

Analysis Done by :

SUB

 

 

Report Prepared by :

SMN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

-- PROFITABILITY

1~10

3

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.